Chitsanu Pancharoen

Author PubWeight™ 33.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med 2007 1.62
2 Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother 2009 1.47
3 Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children. Pediatr Infect Dis J 2005 1.26
4 Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children. AIDS Res Ther 2011 1.22
5 Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010 1.04
6 Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age. J Allergy Clin Immunol 2010 1.00
7 Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: an echocardiographic study. Intensive Care Med 2003 1.00
8 Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J 2010 0.99
9 Seroprevalence of anti-RSV IgG in Thai children aged 6 months to 5 years. Asian Pac J Allergy Immunol 2003 0.96
10 Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother 2012 0.96
11 Serum and urine sodium levels in dengue patients. Southeast Asian J Trop Med Public Health 2005 0.89
12 Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res Ther 2006 0.88
13 The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Vaccine 2011 0.87
14 Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS One 2008 0.86
15 A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther 2008 0.85
16 The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months. J Med Assoc Thai 2005 0.84
17 Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J 2014 0.84
18 Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease. J Neurol 2006 0.84
19 The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2011 0.81
20 Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression. Vaccine 2011 0.81
21 Epstein-Barr virus-associated leiomyosarcoma of the iris in a child infected with human immunodeficiency virus. Arch Ophthalmol 2003 0.79
22 Frequency and clinical course of invasive pneumococcal disease caused by penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae in Thai children. J Med Assoc Thai 2010 0.79
23 Nephelometry determined serum immunoglobulin isotypes in healthy Thai children aged 2-15 years. Microbiol Immunol 2012 0.79
24 Long-term lopinavir/ritonavir monotherapy in HIV-infected children. Pediatr Infect Dis J 2013 0.78
25 Simplifying antiretroviral therapy to lopinavir/ritonavir monotherapy did not improve quality of life and therapy adherence in pretreated HIV-infected children. AIDS Res Hum Retroviruses 2013 0.78
26 Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents. Clin Infect Dis 2007 0.78
27 Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996-2000). Southeast Asian J Trop Med Public Health 2005 0.78
28 Acceptability of oral typhoid vaccine in Thai children. Southeast Asian J Trop Med Public Health 2003 0.78
29 Immunoglobulin values in healthy Thai children aged ≤ 24 months determined by nephelometry. Asian Pac J Allergy Immunol 2013 0.77
30 Prevalence of parvovirus B19 infection in Thai young adults. Southeast Asian J Trop Med Public Health 2003 0.77
31 Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors. Int J Infect Dis 2009 0.77
32 Undetectable plasma HIV-1 RNA with strong gag-pol specific interferon-gamma ELISPOT response in an HIV-1 clade A/E-infected child untreated with antiretroviral therapy. Asian Pac J Allergy Immunol 2004 0.77
33 Risk factors for Epstein-Barr virus infection in Thai infants. Southeast Asian J Trop Med Public Health 2003 0.76
34 Typhoid fever in children: experience in King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2002 0.76
35 Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E. Clin Infect Dis 2004 0.76
36 Invasive pneumococcal infection in neonates: 3 case reports. J Med Assoc Thai 2010 0.76
37 Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine. Hum Vaccin Immunother 2014 0.75
38 Long-Term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization. Pediatr Infect Dis J 2016 0.75
39 Concomitant dengue infection and Kawasaki disease in an infant: a case report and literature review. J Med Assoc Thai 2005 0.75
40 Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand. J Med Assoc Thai 2016 0.75
41 Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease. J Med Assoc Thai 2007 0.75
42 Antibody persistence after primary and booster doses of a pentavalent vaccine against diphtheria, tetanus, acellular pertussis, inactivated poliovirus, haemophilus influenzae type B vaccine among Thai children at 18-19 months of age. Southeast Asian J Trop Med Public Health 2012 0.75
43 Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6 months of age in infants in Thailand. Southeast Asian J Trop Med Public Health 2010 0.75
44 Henoch-Schönlein purpura and thrombocytopenia after planned antiretroviral treatment interruption in a Thai girl with HIV infection. Int J Infect Dis 2008 0.75
45 Incidence and risk factors for non-nucleoside reverse transcriptase inhibitors (NNRTI)-related rash in Thai children with HIV infection. J Med Assoc Thai 2007 0.75
46 Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children. AIDS 2011 0.75
47 Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus. Jpn J Infect Dis 2016 0.75
48 Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Southeast Asian J Trop Med Public Health 2009 0.75
49 Anesthesia in HIV-infected children. Paediatr Anaesth 2007 0.75
50 Low dose lopinavir/ritonavir tablet achieves adequate pharmacokinetic parameters in HIV-infected Thai adolescents. Antivir Ther 2011 0.75
51 Behavioral and emotional problems in Thai children with HIV infection compared to children with and without other chronic diseases. J Int Assoc Physicians AIDS Care (Chic) 2008 0.75